Knocking down FNBP1L, ARHGAP24, and ATP6V1B1 in CD4+ T cells did not enhance HIV-1 infection, contrasting sharply with the significant effects observed in MDDCs (Fig. 5C). This evidence concerns the gene CD4 and HIV-1 infection.